Clinical Evidence: Blood Pressure Reductions in GLP-1 Trials The LEADER trial, which followed over 9,000 people taking liraglutide (a similar GLP-1 drug), documented average systolic blood pressure drops of 23 mmHg within the first weeks of treatment
[DOI] [PubMed] [Google Scholar] 247.Van den Bersselaar L.R., Snoeck M.M.J., Gubbels M., Riazi S., Kamsteeg E.J., Jungbluth H., Voermans N.C
Our Whittier team prioritizes your health by offering products known for quality and consistent outcomes
Understanding your tirzepatide pen & prescription Tirzepatide is a dual GIP and GLP-1 receptor agonist , which means it mimics two natural hormones in your body that regulate appetite and blood sugar, making it effective for both diabetes and weight management
In this study, we have shown that s.c